The newly formed entity will operate in the pharmaceuticals sector and has been set up to expand the company's contract manufacturing and other pharmaceutical manufacturing operations ...

The government has imposed a Minimum Import Price fixed at ₹2,216/kg for Penicillin G and is expected to provide a ...

The United States Food and Drug Administration (USFDA) has raised multiple concerns regarding manufacturing practices, documentation standards and contamination risks at Aurobindo ...

The US FDA reportedly found that the equipment was not cleaned for years at the plant, with presence of E. Coli and bird ...

The shares of Aurobindo Pharma will be in focus in today's session, as the USFDA issued a Form 483 with a total of nine observations post the inspection. The Hyderabad-based company, in an exchange ...

Indian pharma leaders emphasize the need for innovation at scale, leveraging AI and collaborations to overcome industry ...

Aurobindo Pharma plans to increase Penicillin-G production to over 10,000 metric tonnes annually in the next 12 months. The Hyderabad-based company's strategies aim to improve profitability through ...

Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located ...

Aurobindo Pharma posted an 8% increase in Q3 net profit to ₹910 crore, aided by steady sales performance and improved operational efficiency across key markets.

At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low.

The US FDA had inspected Aurobindo's Unit-7 between January 28 and February 10, 2026. The inspection observations pointed to ...

Aurobindo Ltd. and Aurobindo USA were hit with a patent infringement lawsuit on Oct. 9 in Delaware District Court. The action, brought by McCarter & English and Arnold & Porter Kaye Scholer on behalf ...